跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
PAZOPANIB-TEVA FC TABLETS 200 MG
Approved
THERAPEUTIC
PAZOPANIB-TEVA FC TABLETS 200 MG
PharOS MT Ltd
🇸🇬 Health Sciences Authority
Approval Date
May 8, 2024
Approval ID
aa9129b1f4bd7916
Company
PharOS MT Ltd
Type
Therapeutic
Approval Details
Approval Id
aa9129b1f4bd7916
Drug Name
PAZOPANIB-TEVA FC TABLETS 200 MG
Product Name
PAZOPANIB-TEVA FC TABLETS 200 MG
Approval Number
SIN17000P
Approval Date
2024-05-08
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
L01XE11
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Pazopanib hydrochloride eqv Pazopanib
200 mg
Pazopanib hydrochloride eqv Pazopanib
200 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 8, 2024
Approval ID
aa9129b1f4bd7916
Type
Therapeutic
Back to HSA Approvals
PAZOPANIB-TEVA FC TABLETS 200 MG - HSA Drug Approval Details